Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information
None Sanofi SA (NASDAQ: SNY) withdrew and refiled the Premerger Notification and Report Form under the Hart-Scott-Rodino Antitrust Improvements Act “following…
Provention Bio Provention Bio Inc None Sanofi Premerger Notification Report Form Hart Scott Rodino Antitrust Improvements Act
Source: biztoc.com